Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1996 Jan 9;93(1):206–210. doi: 10.1073/pnas.93.1.206

Increasing DNA repair methyltransferase levels via bone marrow stem cell transduction rescues mice from the toxic effects of 1,3-bis(2-chloroethyl)-1-nitrosourea, a chemotherapeutic alkylating agent.

R Maze 1, J P Carney 1, M R Kelley 1, B J Glassner 1, D A Williams 1, L Samson 1
PMCID: PMC40207  PMID: 8552605

Abstract

The chloroethylnitrosourea (CNU) alkylating agents are commonly used for cancer chemotherapy, but their usefulness is limited by severe bone marrow toxicity that causes the cumulative depletion of all hematopoietic lineages (pancytopenia). Bone marrow CNU sensitivity is probably due to the inefficient repair of CNU-induced DNA damage; relative to other tissues, bone marrow cells express extremely low levels of the O6-methylguanine DNA methyltransferase (MGMT) protein that repairs cytotoxic O6-chloroethylguanine DNA lesions. Using a simplified recombinant retroviral vector expressing the human MGMT gene under control of the phosphoglycerate kinase promoter (PGK-MGMT) we increased the capacity of murine bone marrow-derived cells to repair CNU-induced DNA damage. Stable reconstitution of mouse bone marrow with genetically modified, MGMT-expressing hematopoietic stem cells conferred considerable resistance to the cytotoxic effects of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), a CNU commonly used for chemotherapy. Bone marrow harvested from mice transplanted with PGK-MGMT-transduced cells showed extensive in vitro BCNU resistance. Moreover, MGMT expression in mouse bone marrow conferred in vivo resistance to BCNU-induced pancytopenia and significantly reduced BCNU-induced mortality due to bone marrow hypoplasia. These data demonstrate that increased DNA alkylation repair in primitive hematopoietic stem cells confers multilineage protection from the myelosuppressive effects of BCNU and suggest a possible approach to protecting cancer patients from CNU chemotherapy-related toxicity.

Full text

PDF
206

Images in this article

207Fig. 1
on p.207
208Fig. 2
on p.208
208Fig. 3
on p.208

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Apperley J. F., Luskey B. D., Williams D. A. Retroviral gene transfer of human adenosine deaminase in murine hematopoietic cells: effect of selectable marker sequences on long-term expression. Blood. 1991 Jul 15;78(2):310–317. [PubMed] [Google Scholar]
  2. Berardi A. C., Wang A., Levine J. D., Lopez P., Scadden D. T. Functional isolation and characterization of human hematopoietic stem cells. Science. 1995 Jan 6;267(5194):104–108. doi: 10.1126/science.7528940. [DOI] [PubMed] [Google Scholar]
  3. Botnick L. E., Hannon E. C., Vigneulle R., Hellman S. Differential effects of cytotoxic agents on hematopoietic progenitors. Cancer Res. 1981 Jun;41(6):2338–2342. [PubMed] [Google Scholar]
  4. Brenner M. K., Rill D. R., Holladay M. S., Heslop H. E., Moen R. C., Buschle M., Krance R. A., Santana V. M., Anderson W. F., Ihle J. N. Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients. Lancet. 1993 Nov 6;342(8880):1134–1137. doi: 10.1016/0140-6736(93)92122-a. [DOI] [PubMed] [Google Scholar]
  5. Brent T. P., Remack J. S. Formation of covalent complexes between human O6-alkylguanine-DNA alkyltransferase and BCNU-treated defined length synthetic oligodeoxynucleotides. Nucleic Acids Res. 1988 Jul 25;16(14B):6779–6788. doi: 10.1093/nar/16.14.6779. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Carter S. K., Schabel F. M., Jr, Broder L. E., Johnston T. P. 1,3-bis(2-chloroethyl)-1-nitrosourea (bcnu) and other nitrosoureas in cancer treatment: a review. Adv Cancer Res. 1972;16:273–332. doi: 10.1016/s0065-230x(08)60343-7. [DOI] [PubMed] [Google Scholar]
  7. Dick J. E., Magli M. C., Huszar D., Phillips R. A., Bernstein A. Introduction of a selectable gene into primitive stem cells capable of long-term reconstitution of the hemopoietic system of W/Wv mice. Cell. 1985 Aug;42(1):71–79. doi: 10.1016/s0092-8674(85)80102-1. [DOI] [PubMed] [Google Scholar]
  8. Du X. X., Keller D., Maze R., Williams D. A. Comparative effects of in vivo treatment using interleukin-11 and stem cell factor on reconstitution in mice after bone marrow transplantation. Blood. 1993 Aug 1;82(3):1016–1022. [PubMed] [Google Scholar]
  9. Engelward B. P., Boosalis M. S., Chen B. J., Deng Z., Siciliano M. J., Samson L. D. Cloning and characterization of a mouse 3-methyladenine/7-methyl-guanine/3-methylguanine DNA glycosylase cDNA whose gene maps to chromosome 11. Carcinogenesis. 1993 Feb;14(2):175–181. doi: 10.1093/carcin/14.2.175. [DOI] [PubMed] [Google Scholar]
  10. Erickson L. C., Laurent G., Sharkey N. A., Kohn K. W. DNA cross-linking and monoadduct repair in nitrosourea-treated human tumour cells. Nature. 1980 Dec 25;288(5792):727–729. doi: 10.1038/288727a0. [DOI] [PubMed] [Google Scholar]
  11. Gale R. P., Butturini A. Autotransplants in leukaemia. Lancet. 1989 Aug 5;2(8658):315–317. doi: 10.1016/s0140-6736(89)90496-0. [DOI] [PubMed] [Google Scholar]
  12. Gerson S. L., Miller K., Berger N. A. O6 alkylguanine-DNA alkyltransferase activity in human myeloid cells. J Clin Invest. 1985 Dec;76(6):2106–2114. doi: 10.1172/JCI112215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Gerson S. L., Trey J. E., Miller K., Berger N. A. Comparison of O6-alkylguanine-DNA alkyltransferase activity based on cellular DNA content in human, rat and mouse tissues. Carcinogenesis. 1986 May;7(5):745–749. doi: 10.1093/carcin/7.5.745. [DOI] [PubMed] [Google Scholar]
  14. Lemischka I. R., Raulet D. H., Mulligan R. C. Developmental potential and dynamic behavior of hematopoietic stem cells. Cell. 1986 Jun 20;45(6):917–927. doi: 10.1016/0092-8674(86)90566-0. [DOI] [PubMed] [Google Scholar]
  15. Lindahl T., Sedgwick B., Sekiguchi M., Nakabeppu Y. Regulation and expression of the adaptive response to alkylating agents. Annu Rev Biochem. 1988;57:133–157. doi: 10.1146/annurev.bi.57.070188.001025. [DOI] [PubMed] [Google Scholar]
  16. Ludlum D. B. DNA alkylation by the haloethylnitrosoureas: nature of modifications produced and their enzymatic repair or removal. Mutat Res. 1990 Nov-Dec;233(1-2):117–126. doi: 10.1016/0027-5107(90)90156-x. [DOI] [PubMed] [Google Scholar]
  17. Luskey B. D., Rosenblatt M., Zsebo K., Williams D. A. Stem cell factor, interleukin-3, and interleukin-6 promote retroviral-mediated gene transfer into murine hematopoietic stem cells. Blood. 1992 Jul 15;80(2):396–402. [PubMed] [Google Scholar]
  18. Markowitz D., Goff S., Bank A. A safe packaging line for gene transfer: separating viral genes on two different plasmids. J Virol. 1988 Apr;62(4):1120–1124. doi: 10.1128/jvi.62.4.1120-1124.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Matijasevic Z., Boosalis M., Mackay W., Samson L., Ludlum D. B. Protection against chloroethylnitrosourea cytotoxicity by eukaryotic 3-methyladenine DNA glycosylase. Proc Natl Acad Sci U S A. 1993 Dec 15;90(24):11855–11859. doi: 10.1073/pnas.90.24.11855. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Maze R., Moritz T., Williams D. A. Increased survival and multilineage hematopoietic protection from delayed and severe myelosuppressive effects of a nitrosourea with recombinant interleukin-11. Cancer Res. 1994 Sep 15;54(18):4947–4951. [PubMed] [Google Scholar]
  21. Mitra S., Kaina B. Regulation of repair of alkylation damage in mammalian genomes. Prog Nucleic Acid Res Mol Biol. 1993;44:109–142. doi: 10.1016/s0079-6603(08)60218-4. [DOI] [PubMed] [Google Scholar]
  22. Moritz T., Mackay W., Glassner B. J., Williams D. A., Samson L. Retrovirus-mediated expression of a DNA repair protein in bone marrow protects hematopoietic cells from nitrosourea-induced toxicity in vitro and in vivo. Cancer Res. 1995 Jun 15;55(12):2608–2614. [PubMed] [Google Scholar]
  23. Moritz T., Patel V. P., Williams D. A. Bone marrow extracellular matrix molecules improve gene transfer into human hematopoietic cells via retroviral vectors. J Clin Invest. 1994 Apr;93(4):1451–1457. doi: 10.1172/JCI117122. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Moritz T., Williams D. A. Gene transfer into the hematopoietic system. Curr Opin Hematol. 1994 Nov;1(6):423–428. [PubMed] [Google Scholar]
  25. Morrison S. J., Uchida N., Weissman I. L. The biology of hematopoietic stem cells. Annu Rev Cell Dev Biol. 1995;11:35–71. doi: 10.1146/annurev.cb.11.110195.000343. [DOI] [PubMed] [Google Scholar]
  26. Neben S., Hellman S., Montgomery M., Ferrara J., Mauch P., Hemman S. Hematopoietic stem cell deficit of transplanted bone marrow previously exposed to cytotoxic agents. Exp Hematol. 1993 Jan;21(1):156–162. [PubMed] [Google Scholar]
  27. Pegg A. E., Wiest L., Mummert C., Stine L., Moschel R. C., Dolan M. E. Use of antibodies to human O6-alkylguanine-DNA alkyltransferase to study the content of this protein in cells treated with O6-benzylguanine or N-methyl-N'-nitro-N-nitrosoguanidine. Carcinogenesis. 1991 Sep;12(9):1679–1683. doi: 10.1093/carcin/12.9.1679. [DOI] [PubMed] [Google Scholar]
  28. Robins P., Harris A. L., Goldsmith I., Lindahl T. Cross-linking of DNA induced by chloroethylnitrosourea is presented by O6-methylguanine-DNA methyltransferase. Nucleic Acids Res. 1983 Nov 25;11(22):7743–7758. doi: 10.1093/nar/11.22.7743. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Samson L., Derfler B., Waldstein E. A. Suppression of human DNA alkylation-repair defects by Escherichia coli DNA-repair genes. Proc Natl Acad Sci U S A. 1986 Aug;83(15):5607–5610. doi: 10.1073/pnas.83.15.5607. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Schabel F. M., Jr Nitrosoureas: a review of experimental antitumor activity. Cancer Treat Rep. 1976 Jun;60(6):665–698. [PubMed] [Google Scholar]
  31. Sorrentino B. P., Brandt S. J., Bodine D., Gottesman M., Pastan I., Cline A., Nienhuis A. W. Selection of drug-resistant bone marrow cells in vivo after retroviral transfer of human MDR1. Science. 1992 Jul 3;257(5066):99–103. doi: 10.1126/science.1352414. [DOI] [PubMed] [Google Scholar]
  32. Tano K., Shiota S., Collier J., Foote R. S., Mitra S. Isolation and structural characterization of a cDNA clone encoding the human DNA repair protein for O6-alkylguanine. Proc Natl Acad Sci U S A. 1990 Jan;87(2):686–690. doi: 10.1073/pnas.87.2.686. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Walker M. D., Alexander E., Jr, Hunt W. E., MacCarty C. S., Mahaley M. S., Jr, Mealey J., Jr, Norrell H. A., Owens G., Ransohoff J., Wilson C. B. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. J Neurosurg. 1978 Sep;49(3):333–343. doi: 10.3171/jns.1978.49.3.0333. [DOI] [PubMed] [Google Scholar]
  34. Williams D. A., Hsieh K., DeSilva A., Mulligan R. C. Protection of bone marrow transplant recipients from lethal doses of methotrexate by the generation of methotrexate-resistant bone marrow. J Exp Med. 1987 Jul 1;166(1):210–218. doi: 10.1084/jem.166.1.210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Wu R. S., Hurst-Calderone S., Kohn K. W. Measurement of O6-alkylguanine-DNA alkyltransferase activity in human cells and tumor tissues by restriction endonuclease inhibition. Cancer Res. 1987 Dec 1;47(23):6229–6235. [PubMed] [Google Scholar]
  36. Yoder M. C., Du X. X., Williams D. A. High proliferative potential colony-forming cell heterogeneity identified using counterflow centrifugal elutriation. Blood. 1993 Jul 15;82(2):385–391. [PubMed] [Google Scholar]
  37. Zitvogel L., Tahara H., Cai Q., Storkus W. J., Muller G., Wolf S. F., Gately M., Robbins P. D., Lotze M. T. Construction and characterization of retroviral vectors expressing biologically active human interleukin-12. Hum Gene Ther. 1994 Dec;5(12):1493–1506. doi: 10.1089/hum.1994.5.12-1493. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES